| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
|
Malik, Asifa
|
|
2013
|
13 |
3 |
p. 292-295
4 p.
|
artikel
|
| 2 |
Bath-PUVA Therapy Decreases Infiltrating CCR4-Expressing Tumor Cells and Regulatory T Cells in Patients With Mycosis Fungoides
|
Kato, Hiroshi
|
|
2013
|
13 |
3 |
p. 273-280
8 p.
|
artikel
|
| 3 |
CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Zheng, Wenli
|
|
2013
|
13 |
3 |
p. 307-314
8 p.
|
artikel
|
| 4 |
CD30-Positive Cutaneous T-Cell Lymphoma and Response to Brentuximab Vedotin: 2 Illustrative Cases
|
Mody, Kabir
|
|
2013
|
13 |
3 |
p. 319-323
5 p.
|
artikel
|
| 5 |
Chronic Lymphocytic Leukemia With Central Nervous System Involvement: A High-Risk Disease?
|
Benjamini, Ohad
|
|
2013
|
13 |
3 |
p. 338-341
4 p.
|
artikel
|
| 6 |
Complete Remission Achieved With Single Agent CNTO 328, an Anti–IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma
|
Chari, Ajai
|
|
2013
|
13 |
3 |
p. 333-337
5 p.
|
artikel
|
| 7 |
Detection of Epstein-Barr Virus and Genotyping Based on EBNA2 Protein in Mexican Patients With Hodgkin Lymphoma: A Comparative Study in Children and Adults
|
Palma, Icela
|
|
2013
|
13 |
3 |
p. 266-272
7 p.
|
artikel
|
| 8 |
Editorial Board/Masthead
|
|
|
2013
|
13 |
3 |
p. A3-
1 p.
|
artikel
|
| 9 |
Epstein-Barr Virus–Induced CD30-Positive Diffuse Large B-Cell Lymphoma in a Patient With Mixed-Phenotypic Leukemia Treated With Clofarabine
|
Bhamidipati, Pavan Kumar
|
|
2013
|
13 |
3 |
p. 342-346
5 p.
|
artikel
|
| 10 |
Erectile Dysfunction Associated With Bortezomib Treatment in a Patient With Multiple Myeloma and Amyloidosis
|
Pri-Chen, Hadass
|
|
2013
|
13 |
3 |
p. 331-332
2 p.
|
artikel
|
| 11 |
Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin
|
Kebriaei, Partow
|
|
2013
|
13 |
3 |
p. 296-301
6 p.
|
artikel
|
| 12 |
Long-Term Follow-Up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody
|
Strati, Paolo
|
|
2013
|
13 |
3 |
p. 287-291
5 p.
|
artikel
|
| 13 |
Non-Hodgkin Lymphomas Presenting as Soft Tissue Masses: A Single Center Experience and Meta-Analysis of the Published Series
|
Derenzini, Enrico
|
|
2013
|
13 |
3 |
p. 258-265
8 p.
|
artikel
|
| 14 |
Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals
|
Abou Mourad, Yasser R.
|
|
2013
|
13 |
3 |
p. 281-286
6 p.
|
artikel
|
| 15 |
Primary Diffuse Large B-Cell Lymphoma of the Ureter in a Patient With HIV: A Case Report and Review of Literature
|
Ruth, Kenneth
|
|
2013
|
13 |
3 |
p. 324-326
3 p.
|
artikel
|
| 16 |
Prognostic Model to Identify Patients With Myelofibrosis at the Highest Risk of Transformation to Acute Myeloid Leukemia
|
Quintás-Cardama, Alfonso
|
|
2013
|
13 |
3 |
p. 315-318.e2
31486 p.
|
artikel
|
| 17 |
Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma
|
Yared, Jean
|
|
2013
|
13 |
3 |
p. 253-257
5 p.
|
artikel
|
| 18 |
Successful Management of Gastric Perforation in Stage IV Diffuse Large B-Cell Lymphoma With Chemoradiation Therapy, Percutaneous Endoscopy Gastrostomy for Gastric Drainage, and Percutaneous Endoscopy Jejunostomy for Nutrition
|
Khadraoui, Hanaa
|
|
2013
|
13 |
3 |
p. 327-330
4 p.
|
artikel
|
| 19 |
Sustained Leukemia-Free State and Molecular Response to Sorafenib in a Patient With Chronic Myelomonocytic Leukemia in Transformation Driven by Homozygous FLT3-ITD Malignant Hematopoiesis
|
Kosmider, Olivier
|
|
2013
|
13 |
3 |
p. 347-350
4 p.
|
artikel
|
| 20 |
Table of Contents
|
|
|
2013
|
13 |
3 |
p. A4-A6
nvt p.
|
artikel
|
| 21 |
The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure
|
Jabbour, Elias
|
|
2013
|
13 |
3 |
p. 302-306
5 p.
|
artikel
|
Tijdschrift beschrijving